| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5605674 | TEVA BRANDED PHARM | Medicinal aerosol formulations |
Feb, 2014
(10 years ago) | |
| US5683677 | TEVA BRANDED PHARM | Medicinal aerosol formulations |
Nov, 2014
(9 years ago) | |
| US5776432 | TEVA BRANDED PHARM | Beclomethasone solution aerosol formulations |
Jul, 2015
(8 years ago) | |
| US6446627 | TEVA BRANDED PHARM | Inhaler dose counter |
Dec, 2017
(6 years ago) | |
| US10695512 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10022509 | TEVA BRANDED PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US9463289 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US11395889 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10086156 | TEVA BRANDED PHARM | Dose counter for inhaler and method for counting doses |
May, 2031
(7 years from now) | |
| US10022510 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US9808587 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10561808 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
Qvar 40 is owned by Teva Branded Pharm.
Qvar 40 contains Beclomethasone Dipropionate.
Qvar 40 has a total of 12 drug patents out of which 4 drug patents have expired.
Expired drug patents of Qvar 40 are:
- US5605674
- US5683677
- US5776432
- US6446627
Qvar 40 was authorised for market use on 15 September, 2000.
Qvar 40 is available in aerosol, metered;inhalation dosage forms.
Qvar 40 can be used as treatment of asthma.
The generics of Qvar 40 are possible to be released after 01 January, 2032.
Drugs and Companies using BECLOMETHASONE DIPROPIONATE ingredient
Market Authorisation Date: 15 September, 2000
Treatment: Treatment of asthma
Dosage: AEROSOL, METERED;INHALATION
QVAR 40 family patents
